Get started
Author

Manu M. Mathew

Observed names: M Mathew, Manu Mathew
ORCID: 0009-0004-4630-4103
Observed ORCID: 0009-0004-4630-4103
OpenAlex ID: A5085967459
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2023 · O Abani, A Abbas, et al. · The Lancet Diabetes & Endocrinology · 41
PDF
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial
2024 · Saul N Faust, Richard Haynes, et al. · The Lancet Child & Adolescent Health · 39
PDF
Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases · 12
PDF
Anti-Maintenance of Certification laws and older physician supply
2024 · Shishir Shakya, Tulasiram Nepal, et al. · Economics Letters · 1
Comparative Analysis of Postgraduate Clinical Integration Pathways for MedicalGraduates: Lessons from the United Kingdomand Europe for the United States
2026 · Manu M. Mathew · Journal of Knowledge Learning and Science Technology
PDF
P-1650. Temporal Trends in Serious Adverse Events Associated with Oral Antivirals During the COVID-19 Pandemic: Insights from the FAERS Database (2020–2023)
2026 · Ashin Siby, Manu Mathew, et al. · Open Forum Infectious Diseases
Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases
PDF
Is Cmv Igg Positivity in Renal Donors & Recipients Predispose to Cmv Disease? – Study From a Tertiary Canter in a Developing Country
2004 · P Gupta, M Dineshkumar, et al. · Transplantation
Works count: 8
Citation count: 93
H-index: 3
I10-index: 3
Year
Topic
Type